USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 194 filers reported holding USANA HEALTH SCIENCES INC in Q2 2020. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $364,284 | -62.4% | 7,511 | -58.5% | 0.00% | -50.0% |
Q4 2023 | $969,624 | -43.9% | 18,090 | -38.7% | 0.00% | -60.0% |
Q3 2023 | $1,729,874 | +106.2% | 29,515 | +121.8% | 0.01% | +150.0% |
Q2 2023 | $838,873 | -11.3% | 13,307 | -11.5% | 0.00% | -33.3% |
Q1 2023 | $945,261 | +21.7% | 15,028 | +3.0% | 0.00% | +50.0% |
Q4 2022 | $776,507 | -44.3% | 14,596 | -3.5% | 0.00% | -33.3% |
Q3 2021 | $1,395,000 | -62.7% | 15,128 | -58.6% | 0.00% | -62.5% |
Q2 2021 | $3,738,000 | +77.2% | 36,498 | +68.9% | 0.01% | +60.0% |
Q1 2021 | $2,110,000 | -54.4% | 21,615 | -64.0% | 0.01% | -61.5% |
Q4 2020 | $4,624,000 | +58.8% | 59,978 | +51.7% | 0.01% | +30.0% |
Q3 2020 | $2,912,000 | -46.8% | 39,532 | -47.0% | 0.01% | -63.0% |
Q2 2020 | $5,475,000 | +425.9% | 74,567 | +313.7% | 0.03% | +237.5% |
Q1 2020 | $1,041,000 | +115.5% | 18,023 | +192.9% | 0.01% | +700.0% |
Q4 2019 | $483,000 | +18.7% | 6,153 | +3.3% | 0.00% | 0.0% |
Q3 2019 | $407,000 | -97.5% | 5,955 | -97.1% | 0.00% | -98.2% |
Q2 2019 | $16,366,000 | +25.5% | 206,042 | +32.5% | 0.06% | +31.0% |
Q1 2019 | $13,042,000 | +2099.3% | 155,499 | +2989.0% | 0.04% | +2000.0% |
Q4 2018 | $593,000 | -89.5% | 5,034 | -89.3% | 0.00% | -86.7% |
Q3 2018 | $5,671,000 | +786.1% | 47,040 | +531.7% | 0.02% | +650.0% |
Q1 2018 | $640,000 | +82.9% | 7,447 | +57.5% | 0.00% | +100.0% |
Q4 2017 | $350,000 | -72.6% | 4,728 | -78.7% | 0.00% | -80.0% |
Q3 2017 | $1,278,000 | -86.9% | 22,150 | -85.4% | 0.01% | -85.7% |
Q2 2017 | $9,753,000 | +203.0% | 152,155 | +172.3% | 0.04% | +218.2% |
Q1 2017 | $3,219,000 | -59.1% | 55,878 | -1.8% | 0.01% | -62.1% |
Q3 2016 | $7,873,000 | +92.2% | 56,908 | +54.8% | 0.03% | +61.1% |
Q2 2016 | $4,096,000 | +149.0% | 36,755 | +199.5% | 0.02% | +125.0% |
Q3 2015 | $1,645,000 | +45.1% | 12,271 | +20.2% | 0.01% | +33.3% |
Q1 2015 | $1,134,000 | -84.6% | 10,206 | -85.8% | 0.01% | -85.4% |
Q4 2014 | $7,358,000 | +1955.3% | 71,721 | +1374.5% | 0.04% | +1950.0% |
Q3 2014 | $358,000 | +25.6% | 4,864 | +33.4% | 0.00% | +100.0% |
Q2 2014 | $285,000 | -85.3% | 3,647 | -85.9% | 0.00% | -90.0% |
Q1 2014 | $1,942,000 | -27.1% | 25,778 | -30.0% | 0.01% | -47.4% |
Q2 2013 | $2,665,000 | – | 36,824 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |